Biofrontera AG announced that the Supervisory Board of Biofrontera AG, by resolution, has appointed Mrs. Pilar de la Huerta as new Chief Financial Officer of Biofrontera AG with effect as of 12 September 2022. Mrs. Pilar de la Huerta has 25 years of experience in the healthcare sector and has held various positions with responsibility as CFO und CEO in technology driven organizations in Pharma and Healthcare.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 EUR | -1.40% | -48.41% | -58.32% |
May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.32% | 11.45M | |
+38.96% | 705B | |
+32.57% | 583B | |
-3.06% | 364B | |
+21.34% | 332B | |
+6.05% | 291B | |
+16.21% | 238B | |
-3.56% | 210B | |
+10.52% | 209B | |
+9.38% | 169B |
- Stock Market
- Equities
- B8FK Stock
- News Biofrontera AG
- Biofrontera AG Announces Appointment of Pilar de la Huerta Martinez as New Chief Financial Officer